ALRN: Aileron Therapeutics, Inc. Stock

by  •  • Comments Off on ALRN: Aileron Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 55.90
Enterprise Value ($M) 83.25
Book Value ($M) 95.23
Book Value / Share 4.40
Price / Book 0.59
NCAV ($M) 9.70
NCAV / Share 0.45
Price / NCAV 5.76

Profitability (mra)
Return on Invested Capital (ROIC) -0.31
Return on Assets (ROA) -2.28
Return on Equity (ROE) -2.61

Liquidity (mrq)
Quick Ratio 3.30
Current Ratio 3.30

Balance Sheet (mrq) ($M)
Current Assets 18.68
Assets 104.22
Liabilities 8.98
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-16 13D/A Satter Muneer A 4.90 -18.34
03-05 13G University Of Texas/texas Am Investment Managment Co 6.20
02-14 13G/A Biotechnology Value Fund L P 0.00 -100.00
02-05 13G/A Kapnick Scott 0.00
2023-11-13 13G BIOS Fund I, LP 9.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ T
2024-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 15,772 93,214 16.92
2024-11-21 38,634 102,448 37.71
2024-11-20 20,864 114,947 18.15
2024-11-19 12,983 40,286 32.23
2024-11-18 25,949 73,719 35.20

(click for more detail)

Similar Companies
ALBT – Avalon GloboCare Corp. ALDX – Aldeyra Therapeutics, Inc.
ALGS – Aligos Therapeutics, Inc. ALVR – AlloVir, Inc.
ALZN – Alzamend Neuro, Inc.


Financial data and stock pages provided by
Fintel.io